ELEVANCE HEALTH, INC.

ELV · CIK 0001156039

19 fiscal years · 69 SEC filings · every number carries its receipt

Revenue (FY)

$199.13B12.5%

FY2025

Net income (FY)

$5.66B5.3%

FY2025

Free cash flow (FY)

$3.17B30.3%

FY2025

Diluted EPS (FY)

$25.211.8%

FY2025

The story, charted

The shape of the business

FY2007–FY2025 · hover any year for its receipt

Revenue & net incomeRevenueNet income

revenue 3.3× since FY2007 · net margin 5.5% → 2.8%

MarginsNet marginFCF margin

FY2025: net 2.8% · free cash flow 1.6% of revenue

Cash engineOperating cash flowFree cash flow

FY2025: $4.29B operating cash − $1.12B capex = $3.17B free cash flow

Returns on capitalReturn on equityReturn on assets

return on equity 12% (FY2008) → 13% (FY2025) · on assets 4.7%

Balance sheetLiabilitiesEquity

FY2025: $121.49B assets · $77.47B liabilities · $43.88B equity

The receipts

ELEVANCE HEALTH, INC.

ELV · CIK 0001156039

19 fiscal years · 69 SEC filings · every number carries its receipt

Revenue (FY)

$199.13B12.5%

FY2025

Net income (FY)

$5.66B5.3%

FY2025

Free cash flow (FY)

$3.17B30.3%

FY2025

Diluted EPS (FY)

$25.211.8%

FY2025

The story, charted

The shape of the business

FY2007–FY2025 · hover any year for its receipt

Revenue & net incomeRevenueNet income

revenue 3.3× since FY2007 · net margin 5.5% → 2.8%

MarginsNet marginFCF margin

FY2025: net 2.8% · free cash flow 1.6% of revenue

Cash engineOperating cash flowFree cash flow

FY2025: $4.29B operating cash − $1.12B capex = $3.17B free cash flow

Returns on capitalReturn on equityReturn on assets

return on equity 12% (FY2008) → 13% (FY2025) · on assets 4.7%

Balance sheetLiabilitiesEquity

FY2025: $121.49B assets · $77.47B liabilities · $43.88B equity

The receipts